LeMaitre Vascular, Inc. (LMAT) is a publicly traded Healthcare sector company. As of May 21, 2026, LMAT trades at $100.60 with a market cap of $2.30B and a P/E ratio of 36.90. LMAT moved +0.22% today. Year to date, LMAT is +23.83%; over the trailing twelve months it is +19.68%. Its 52-week range spans $71.42 to $118.01. Analyst consensus is strong buy with an average price target of $122.14. Rallies surfaces LMAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes LMAT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $100.60 |
| Market Cap | $2.30B |
| P/E Ratio | 36.90 |
| EPS | $2.76 |
| Dividend Yield | 0.25% |
| 52-Week High | $118.01 |
| 52-Week Low | $71.42 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $256.28M |
| Net Income | $62.40M |
| Gross Margin | 72.39% |
8 analysts cover LMAT: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $122.14.